Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

4.4K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serine protease HTRA1 is a common autoantigen in membranous nephropathy in patients of 80 years and older.

Kidney international·2026
Same author

[Primary glomerulonephritides].

Innere Medizin (Heidelberg, Germany)·2026
Same author

Proteolytic profiling of human plasma reveals an immunoactive complement C3 fragment.

The EMBO journal·2025
Same author

Spatiotemporal interaction of immune and renal cells controls glomerular crescent formation in autoimmune kidney disease.

Nature immunology·2025
Same author

The authors reply.

Kidney international·2025
Same author

Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma.

Leukemia·2025

Related Experiment Video

Updated: Mar 9, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

7.1K

THSD7A expression in human cancer.

Phillip R Stahl1, Elion Hoxha2, Thorsten Wiech1

  • 1Institute of Pathology, University Medical Center Hamburg-Eppendorf.

Genes, Chromosomes & Cancer
|December 31, 2016
PubMed
Summary
This summary is machine-generated.

Thrombospondin Type-1 Domain containing 7A (THSD7A) may act as a tumor antigen. Its expression varies across tumor types and correlates with specific markers and prognosis, suggesting a role in cancer development and therapy.

More Related Videos

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.5K
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

13.0K

Related Experiment Videos

Last Updated: Mar 9, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

7.1K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.5K
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

13.0K

Area of Science:

  • Oncology
  • Nephrology
  • Immunology

Background:

  • Thrombospondin Type-1 Domain containing 7A (THSD7A) is implicated in membranous nephropathy.
  • THSD7A-associated malignancy was observed in a patient with THSD7A-associated membranous nephropathy.
  • The potential role of THSD7A as a tumor antigen requires further investigation.

Purpose of the Study:

  • To investigate the role of THSD7A as a potential tumor antigen.
  • To evaluate THSD7A expression across a wide range of tumor types.
  • To correlate THSD7A expression with tumor-specific markers and patient prognosis.

Main Methods:

  • Immunohistochemistry was performed on over 20,000 tissue spots from more than 70 tumor entities using tissue microarrays.
  • THSD7A expression patterns were analyzed in various neoplasms.
  • Correlation between THSD7A expression and tumor-specific markers was assessed.

Main Results:

  • THSD7A expression exhibited significant variability across different tumor types and staining patterns.
  • Both increased and decreased THSD7A expression (compared to non-tumor tissue) were associated with tumor-specific markers.
  • THSD7A expression levels demonstrated prognostic value in different tumor entities.

Conclusions:

  • THSD7A is a potential tumor antigen with variable expression in neoplasms.
  • Altered THSD7A expression is linked to tumor characteristics and prognosis.
  • Further research is warranted to elucidate the role of THSD7A in tumor development and therapeutic strategies.